Protein kinase Cε regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors

Biochemistry

Volumn 49, Issue 23, 2010, Pages 4766-4778

  Batarseh, Amani ^a,b   Li, Jiehan ^b,c   Papadopoulos, Vassilios ^a,b,c  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATOR PROTEIN-1; CELL FUNCTIONS; DOWNSTREAM TARGET; GLANDULAR TISSUE; LEYDIG CELLS; MRNA LEVEL; NEUROLOGICAL DISEASE; OVER-EXPRESSION; PATHOLOGICAL CONDITIONS; PHORBOL 12 MYRISTATE 13 ACETATES; PROMOTER ACTIVITIES; PROMOTER LEVELS; PROTEIN KINASE C; PROTEIN LEVEL; SIGNAL TRANSDUCERS; SIGNAL TRANSDUCTION PATHWAYS; SPECIFIC INHIBITORS; TRANSLOCATORS;

BACTERIOPHAGES; BINDING ENERGY; BINDING SITES; BIOCHEMISTRY; CELL CULTURE; CHEMICAL ACTIVATION; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION; TRANSCRIPTION FACTORS;

GENE EXPRESSION REGULATION;

CARRIER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C JUN; PROTEIN KINASE C EPSILON; RAF PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; LEYDIG CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE TARGETING; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MAP KINASE SIGNALING SYSTEM; MICE; NIH 3T3 CELLS; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C-EPSILON; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTORS, GABA; STAT3 TRANSCRIPTION FACTOR;

EID: 77953283910     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi100020e     Document Type: Article

References (33)

1. Casellas, P., Galiegue, S., and Basile, A. S. (2002) Peripheral benzodiazepine receptors and mitochondrial function Neurochem. Int. 40, 475-486
2. Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapere, J. J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M. R., and Gavish, M. (2006) Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function Trends Pharmacol. Sci. 27, 402-409
3. Braestrup, C. and Squires, R. F. (1977) Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding Proc. Natl. Acad. Sci. U.S.A. 74, 3805-3809
4. Gavish, M., Bachman, I., Shoukrun, R., Katz, Y., Veenman, L., Weisinger, G., and Weizman, A. (1999) Enigma of the peripheral benzodiazepine receptor Pharmacol. Rev. 51, 629-650
5. Giatzakis, C. and Papadopoulos, V. (2004) Differential utilization of the promoter of peripheral-type benzodiazepine receptor by steroidogenic versus nonsteroidogenic cell lines and the role of Sp1 and Sp3 in the regulation of basal activity Endocrinology 145, 1113-1123
6. Galiegue, S., Casellas, P., Kramar, A., Tinel, N., and Simony-Lafontaine, J. (2004) Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival Clin. Cancer Res. 10, 2058-2064
7. Han, Z., Slack, R. S., Li, W., and Papadopoulos, V. (2003) Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression J. Recept. Signal. Transduct. Res. 23, 225-238
8. Hardwick, M., Fertikh, D., Culty, M., Li, H., Vidic, B., and Papadopoulos, V. (1999) Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol Cancer Res. 59, 831-842
9. Katz, Y., Ben-Baruch, G., Kloog, Y., Menczer, J., and Gavish, M. (1990) Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries Clin. Sci. (London) 78, 155-158
10. Maaser, K., Grabowski, P., Sutter, A. P., Hopfner, M., Foss, H. D., Stein, H., Berger, G., Gavish, M., Zeitz, M., and Scherubl, H. (2002) Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer Clin. Cancer Res. 8, 3205-3209
11. Papadopoulos, V. and Lecanu, L. (2009) Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma Exp. Neurol. 219, 53-57
12. Amri, H., Drieu, K., and Papadopoulos, V. (2003) Transcriptional suppression of the adrenal cortical peripheral-type benzodiazepine receptor gene and inhibition of steroid synthesis by ginkgolide B Biochem. Pharmacol. 65, 717-729
13. Gazouli, M., Yao, Z. X., Boujrad, N., Corton, J. C., Culty, M., and Papadopoulos, V. (2002) Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha Endocrinology 143, 2571-2583
14. Veenman, L., Papadopoulos, V., and Gavish, M. (2007) Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response Curr. Pharm. Des. 13, 2385-2405
15. Giatzakis, C., Batarseh, A., Dettin, L., and Papadopoulos, V. (2007) The role of Ets transcription factors in the basal transcription of the translocator protein (18 kDa) Biochemistry 46, 4763-4774
16. Batarseh, A., Giatzakis, C., and Papadopoulos, V. (2008) Phorbol-12-myristate 13-acetate acting through protein kinase Cepsilon induces translocator protein (18-kDa) TSPO gene expression Biochemistry 47, 12886-12899
17. da Rocha, A. B., Mans, D. R., Regner, A., and Schwartsmann, G. (2002) Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas? Oncologist 7, 17-33
18. Garczarczyk, D., Toton, E., Biedermann, V., Rosivatz, E., Rechfeld, F., Rybczynska, M., and Hofmann, J. (2009) Signal transduction of constitutively active protein kinase C epsilon Cell. Signalling 21, 745-752
19. Griner, E. M. and Kazanietz, M. G. (2007) Protein kinase C and other diacylglycerol effectors in cancer Nat. Rev. Cancer 7, 281-294
20. Ono, Y., Fujii, T., Ogita, K., Kikkawa, U., Igarashi, K., and Nishizuka, Y. (1988) The structure, expression, and properties of additional members of the protein kinase C family J. Biol. Chem. 263, 6927-6932
21. Aziz, M. H., Manoharan, H. T., Church, D. R., Dreckschmidt, N. E., Zhong, W., Oberley, T. D., Wilding, G., and Verma, A. K. (2007) Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer Cancer Res. 67, 8828-8838
22. Aziz, M. H., Manoharan, H. T., Sand, J. M., and Verma, A. K. (2007) Protein kinase Cepsilon interacts with Stat3 and regulates its activation that is essential for the development of skin cancer Mol. Carcinog. 46, 646-653
23. Kirkland, R. A. and Franklin, J. L. (2003) Prooxidant effects of NGF withdrawal and MEK inhibition in sympathetic neurons Antioxid. Redox Signaling 5, 635-639
24. Racz, G. Z., Szucs, A., Szlavik, V., Vag, J., Burghardt, B., Elliott, A. C., and Varga, G. (2006) Possible role of duration of PKC-induced ERK activation in the effects of agonists and phorbol esters on DNA synthesis in Panc-1 cells J. Cell Biochem. 98, 1667-1680
25. Imler, J. L. and Wasylyk, B. (1989) AP1, a composite transcription factor implicated in abnormal growth control Prog. Growth Factor Res. 1, 69-77
26. Lawrence, M. C., Jivan, A., Shao, C., Duan, L., Goad, D., Zaganjor, E., Osborne, J., McGlynn, K., Stippec, S., Earnest, S., Chen, W., and Cobb, M. H. (0 AD) The roles of MAPKs in disease Cell Res. 18, 436-442
27. Akira, S. (1999) Functional roles of STAT family proteins: lessons from knockout mice Stem Cells 17, 138-146
28. Papadopoulos, V., Amri, H., Boujrad, N., Cascio, C., Culty, M., Garnier, M., Hardwick, M., Li, H., Vidic, B., Brown, A. S., Reversa, J. L., Bernassau, J. M., and Drieu, K. (1997) Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis Steroids 62, 21-28
29. Yoo, J. Y., Wang, W., Desiderio, S., and Nathans, D. (2001) Synergistic activity of STAT3 and c-Jun at a specific array of DNA elements in the β2-macroglobulin promoter J. Biol. Chem. 276, 26421-26429
30. Zhang, X., Wrzeszczynska, M. H., Horvath, C. M., and Darnell, J. E., Jr. (1999) Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation Mol. Cell. Biol. 19, 7138-7146
31. Ginsberg, M., Czeko, E., Muller, P., Ren, Z., Chen, X., and Darnell, J. E., Jr. (2007) Amino acid residues required for physical and cooperative transcriptional interaction of STAT3 and AP-1 proteins c-Jun and c-Fos Mol. Cell. Biol. 27, 6300-6308
32. Ghosh, D., Ezashi, T., Ostrowski, M. C., and Roberts, R. M. (2003) A central role for Ets-2 in the transcriptional regulation and cyclic adenosine 5′-monophosphate responsiveness of the human chorionic gonadotropin-beta subunit gene Mol. Endocrinol. 17, 11-26
33. Plaza-Menacho, I., van der, S. T., Hollema, H., Gimm, O., Buys, C. H., Magee, A. I., Isacke, C. M., Hofstra, R. M., and Eggen, B. J. (2007) Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation J. Biol. Chem. 282, 6415-6424